First-Line Treatment for Uncomplicated E. coli UTI

Recommended First-Line Agents

The European Urology guidelines recommend fosfomycin trometamol (3g single dose), nitrofurantoin (100mg twice daily for 5 days), or pivmecillinam (400mg three times daily for 3-5 days) as first-line treatment options for uncomplicated E. coli urinary tract infections 1, 2, 3
Nitrofurantoin has excellent activity against E. coli with minimal resistance development over time, and has a low propensity for collateral damage 4, 5, 6
Fosfomycin trometamol has a convenient single-dose regimen with good compliance, and is effective against multidrug-resistant pathogens including ESBL-producing E. coli 8
Pivmecillinam is specific for urinary tract infections with minimal resistance, and has a low propensity for collateral damage 5, 8

Trimethoprim-Sulfamethoxazole (TMP-SMX) is only recommended if local E. coli resistance is <20%, and should not be used in the first or last trimester of pregnancy 1, 2, 4, 9
Cephalosporins are associated with greater collateral damage than first-line agents, and have inferior efficacy compared to other UTI antimicrobials 1, 2, 6, 7

Local resistance patterns should guide empiric therapy selection, and E. coli accounts for 75-95% of uncomplicated UTIs 4, 5
Fluoroquinolones should be avoided for uncomplicated UTIs due to increasing resistance and greater collateral damage to intestinal flora 7
Amoxicillin or ampicillin should not be used empirically due to high resistance rates 9

Routine post-treatment urinalysis or cultures are not indicated for asymptomatic patients, but should be considered for persistent or recurrent symptoms within 2-4 weeks 1, 2
For recurrent infections, consider different treatment strategies including prophylaxis 1, 2

Recent antibiotic use (within 3-6 months) is a risk factor for resistance to that agent 5
Diagnosis of uncomplicated cystitis can be made with high probability based on symptoms (dysuria, frequency, urgency) and absence of vaginal discharge 1, 2